Valganciclovir hydrochloride

CAS : 175865-59-5

Ref. 3D-FV28652

Informations sur le produit

• Nom: Valganciclovir hydrochloride
• Synonymes: 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, 2-[(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl L-valinate hydrochloride (1:1), <span class="text-smallcaps">L</span>-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, hydrochloride (1:1), <span class="text-smallcaps">L</span>-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, monohydrochloride, L-Valine, 2-[(2-Amino-1,6-Dihydro-6-Oxo-9H-Purin-9-Yl)Methoxy]-3-Hydroxypropyl Ester, Monohydrochloride, L-Valine,2-[(2-Amino-1,6-Dihydro-6-Oxo-9H-Purin-9-Yl)Methoxy]-3-Hydroxypropylester,Monohydrochloride, Ro 107-9070/194, Rs 079070-194, Valcyte, Valganciclovir Hcl
• CAS: 175865-59-5

Description

Valganciclovir hydrochloride is a prodrug of ganciclovir. It is an antiviral drug used for the treatment and prevention of cytomegalovirus (CMV) infections. Valganciclovir hydrochloride is a prodrug of ganciclovir, which is converted to the active form in humans by esterases in the liver. Valganciclovir hydrochloride has been shown to be effective against CMV and other herpesviruses, such as herpes zoster virus, varicella-zoster virus, and Epstein-Barr virus. It has minimal toxicity and does not cause bone marrow suppression or organ damage at low doses. Valganciclovir hydrochloride also has a matrix effect that reduces the bioavailability of other drugs taken concurrently with it.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 390.82 g/mol
• Formule: C₁₄H₂₃ClN₆O₅
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder